Q/C TECHNOLOGIES, INC.

QCLS · In Vitro and in Vivo Diagnostic Substances

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • QCLS · 62856X300 - Common Stock, par value $0.001 per share
  • MYMD · 62856X102 - COM
Company details and SEC sources

CIK 0001321834 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
QCLS on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
In Vitro and in Vivo Diagnostic Substances (Office of Life Sciences)
Business address
1185 Avenue Of The Americas, Suite 249, New York, NY, 10036
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
TNF Pharmaceuticals Inc. (to 10 Sep 2025) MyMD Pharmaceuticals Inc. (to 01 Jul 2024) Akers Biosciences Inc. (to 16 Apr 2021) Akers Biosciences Inc (to 11 Apr 2017)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .